Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296

Expensive Underperformer

Download real time

1420.90 8.40 (0.59%)

44.22% Gain from 52W Low

1.4M NSE+BSE Volume

NSE 24 Apr, 2025 3:31 PM (IST)

40,097.9

Market Cap

High in industry

0.9

Beta 1Year

Low volatility

Glenmark Pharmaceuticals Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Glenmark Pharmaceuticals Ltd. from all sources in a single place.

Is Glenmark Pharmaceuticals Ltd. worth buying?

558 Votes:

Buy 79.21%

Sell 13.62%

Hold 7.17%

RESEARCH REPORTS

Accumulate SEE REPORTS >

Not Rated SEE REPORTS >